Ligand Pharmaceuticals Inc (LGND)

Free Cash Flow Growth

229.23%

TTM · Period ending:

LGND logo

LGND Free Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported229.23%
LGND TTM Free Cash Flow YoY % (-2.68% → 229.23%)
High-resolution chart · PNG

LGND free cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Ligand Pharmaceuticals Inc Free Cash Flow Growth — Trailing twelve months (TTM)
Period endingFree Cash Flow Growth
229.2273%
246.4232%
-38.9004%
-47.7659%
-8.5238%
10.3672%
76.9326%
-34.5408%
-55.3952%
-68.8879%
-62.0844%
-3.5714%
1.7311%
-2.8698%
78.5407%
149.7598%
223.4388%
182.069%
40.8732%
-9.8333%
21.6836%
162.6451%
248.327%
13,346.4744%
-25.9138%
-135.919%
-117.5049%
-100.1643%
-82.6861%
31.9833%
110.8131%
149.0176%
193.1519%
173.8714%
149.1825%
179.538%
223.1925%
36.5419%
12.3607%
1.9741%
-4.5545%
74.7891%
92.0956%
37.7646%
36.8784%
32.5332%
1.9933%
1,838.1379%
938.3106%
342.2365%
285.7008%
-125.3231%
-140.5346%
-137.9717%
-578.64%
153.5966%
130.7061%
75.2986%
95.3937%
71.1086%
54.4477%
60.2662%
20.9364%
-5.9077%
-12.1604%
27.7189%
-62.5142%
25.5549%
21.7613%
42.4647%
78.4856%
79.1841%
80.4068%
62.355%
30.0326%
-292.335%
-340.9543%
-274.4882%
-415.2363%
-276.3185%
-648.9841%
-1,354.5687%
-1,366.5581%
32.8037%
159.6045%
21.1829%
185.6915%
12.4637%
37.321%
107.9406%
91.1258%
10.5532%
17.5879%
-285.0489%
-29.2185%
17.7441%
29.419%
80.2901%
54.8307%
68.7202%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.